MILLENNIUM NEWSROOM
Search
The 4th National POSH Conclave & Excellence Awards witnessed a landmark MoU between the Delhi Government and NoMeansNo Foundation, reinforcing collaborative efforts to strengthen workplace safety, POSH compliance and organizational accountability across India.
Rework caused by tile failures is becoming a major business challenge for the construction industry. Walplast Products Pvt. Ltd. Managing Director Kaushal Mehta explains why quality installation systems are essential for improving productivity, sustainability, and long-term project value.
DeepFacts Pvt. Ltd. has announced plans to expand its AI-powered remote patient monitoring platform, proRITHM, across southern India before targeting nationwide growth by early 2027 and a U.S. market entry by late 2027 or early 2028.
Formula 1 and the FIA have confirmed that Malaysia will host the Formula 1 Gulf Air Bahrain Grand Prix at Sepang International Circuit from October 2–4, 2026, following an agreement between Bahrain and Malaysia.
Kush Maini secured his third podium of the 2026 FIA Formula 2 season with a second-place finish at the Hungaroring after an untimely Virtual Safety Car disrupted his dominant Feature Race.
Defending champions Kashi Rudras have completed their 18-player squad for UPT20 Season 4, adding six players at the Agra auction, including all-rounder Mohammad Sharim as their marquee signing.
The 4th Hockey India Sub-Junior Women Academy Championship 2026 (Zone A & B) begins on July 26 in Gwalior, featuring 15 academies across four pools battling for the championship title.
The Indian Sub-Junior Men's Team defeated Oman and Pakistan to reach the FIH Youth Hockey5s Asian Championship 2026 final, while the women's team bounced back with a 10-0 win over Uzbekistan to book a semi-final clash against Kazakhstan.
Alvaro Robles starred with two victories as Dempo Goa Challengers defeated Dabang Delhi TTC 8-2 to become the first finalists of Butterfly UTT Season 7.
OneSource Specialty Pharma posted a strong start to FY27, reporting a 37% year-on-year increase in revenue and a 39% rise in EBITDA, driven by semaglutide commercialisation and new customer wins.